by goldfishadmin | Aug 12, 2016 | about column
Our scientists and management team are committed to the best we can bring to bear in pursuit of new therapies. We are drug hunters....
by goldfishadmin | Oct 22, 2015 | News
Orphagen Pharmaceuticals, a privately-held pharmaceutical company, announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded the company a highly competitive Phase 1 Small Business Innovative Research...
by goldfishadmin | Jul 1, 2015 | News
Orphagen Pharmaceuticals, a privately-held pharmaceutical company, announced today that the National Institutes of Health (NIH) National Cancer Institute (NCI) has awarded the company $224,954 under the Small Business Innovative Research (SBIR) program to identify...
by goldfishadmin | Mar 30, 2015 | News
Orphagen Pharmaceuticals announced today that Robin Jackman, CEO of Leading BioSciences, has been appointed to the Board of Directors. “Robin brings crucial experience to our Board in finance and fund-raising. This comes on top of his excellent record in guiding two...
by goldfishadmin | Sep 1, 2014 | News
Orphagen Pharmaceuticals, a privately-held pharmaceutical company, announced today that the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded the company $223,229 under the Small Business...
